Tsubaki, M.; Takeda, T.; Matsuda, T.; Seki, S.; Tomonari, Y.; Koizumi, S.; Nagatakiya, M.; Katsuyama, M.; Yamamoto, Y.; Tsurushima, K.;
et al. Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells. Biomedicines 2021, 9, 33.
https://doi.org/10.3390/biomedicines9010033
AMA Style
Tsubaki M, Takeda T, Matsuda T, Seki S, Tomonari Y, Koizumi S, Nagatakiya M, Katsuyama M, Yamamoto Y, Tsurushima K,
et al. Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells. Biomedicines. 2021; 9(1):33.
https://doi.org/10.3390/biomedicines9010033
Chicago/Turabian Style
Tsubaki, Masanobu, Tomoya Takeda, Takuya Matsuda, Shiori Seki, Yoshika Tomonari, Shoutaro Koizumi, Miki Nagatakiya, Mai Katsuyama, Yuuta Yamamoto, Katsumasa Tsurushima,
and et al. 2021. "Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells" Biomedicines 9, no. 1: 33.
https://doi.org/10.3390/biomedicines9010033
APA Style
Tsubaki, M., Takeda, T., Matsuda, T., Seki, S., Tomonari, Y., Koizumi, S., Nagatakiya, M., Katsuyama, M., Yamamoto, Y., Tsurushima, K., Ishizaka, T., & Nishida, S.
(2021). Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells. Biomedicines, 9(1), 33.
https://doi.org/10.3390/biomedicines9010033
